Quiros MF

Language: Spanish
References: 20
Page: 241-249
PDF size: 474.14 Kb.

ABSTRACT

Thromboangiitis Obliterans or Buerger’s Disease is an inflammatory non atherosclerotic segmental and occlusive disease affecting small and medium sized arteries and veins, mostly in the vascular territories below the elbow and knee. Its development and progression has a strong relationship with tobacco use and it manifests itself as an endarteritis with thrombosis and recanalization of the affected vessels producing peripheral ischemia, superficial thrombophlebitis and Raynaud’s phenomenon. Smoking cessation is the only form of treatment with proven efficacy to stop the progression of the disease.

REFERENCES

1. Akkila P. Thromboangiitis Obliterans (Buerger’s disease). Orphanet Encyclopedia, September 2005.

2. Arkkila P. Thromboangiitis Obliterans (Buerger’s disease). Orphanet journal of Rare Diseases 2006; 1:14.

3. Batsis JA, Casey KK. Thromboangiitis Obliterans (Buerger’s disease). Mayo Clinic Proceedings, April 2007; 82(4):448.

4. Buerger L. Trombo-Angiitis Obliterans: A study of the vascular lesions leading to presenile spontaneous gangrene. American Journal of the Medical Sciences 1908; 136: 567-80.

5. Cronenwett JL, Johnston KW, et al. Rutherford’s Vascular Surgery. 7th Edition 2005; 1169-86. ISBN: 978-1-4160-5223-4.

6. Donas KP, Schulte S, et al. The role of epidural spinal cord stimulation in the treatment of Buerger’s Disease. Journal of Vascular Surgery 2005; 41: 830-6.

7. Durdu S, Ruchan-Akar A, et al. Autologous bone marrow mononuclear cell implantation for patients with Rutherford’s grade II-III Thromboangiitis Obliterans. Journal of vascular surgery 2006; 44; 4: 732-9.

8. Faizer R, Forbes TL. Buerger’s Disease. Journal of vascular Surgery 2007; 46: 812.

9. Fernández-Miranda C, Rubro R, et al. Tromboangitis Obliterante. Estudio de 41 casos. Medicina Clínica 1993; 101: 321-6.

10. Jashwantlal J, Krishnan A. Buerger’s Disease-Management by Ilizarov’s technique of horizontal distraction. A retrospective study of 60 cases. Indian Journal of Surgery 2011; 73 (1): 40-7.

11. Kobayashi M, Ito M, et al. Inmunohistochemical analysis of arterial Wall cell infiltration in Buerger’s Disease (Endarteritis Obliterans). Journal of Vascular Surgery 1999; 29: 451-8.

12. Kobayashi M, Kurose K, et al. Ischemic intestinal involvement in a patient with Buerger’s Disease: Case report and literature review. Journal of vascular Surgery 2003; 38: 170-4.

13. Kobayashi K, Nishikimi N, et al. Current pathological and clinical aspects of Buerger’s disease in Japan. Annals of Vascular Surgery 2006; 20; 1: 148-56.

14. Lawrence PF, Lund OI, et al. Substitution of smokeless tobacco for cigarettes in Buerger’s Disease does not prevent limb loss. Journal of Vascular Surgery 2008; 48: 210-2.

15. Matsushita M, Kuzuya A, et al. Buerger’s Disease in a 19 year old woman. Journal of Vascular Surgery 2003; 38: 175-9.

16. Matsushita M, Shionoya S, et al. Urinary cotinine measurement in patients with Buerger’s Disease – Effects of active and passive smoking on the disease process. Journal of Vascular Surgery 1991; 14; 1: 53-8.

17. Ohta T, Ishioashi H, et al. Clinical and social consequences of Buerger’s Disease. Journal of Vascular Surgery 2004; 39: 176-80.

18. Olin JW. Thromboangiitis Obliterans (Buerger’s Disease). The New England Journal of medicine 2000; 343; 12: 864-9.

19. Piazza G, et al. Thromboangiitis Obliterans. Circulation 2010; 121: 1858-61.

20. Szendro G, et al. Study of the factors affecting blood viscosity in patients with Thromboangiitis Obliterans. Journal of Vascular Surgery 1988; 7: 759-62.